Eledon Pharmaceuticals Inc (ELDN)
SG&A Expenses
$4.64M
Quarterly · Period ending: · USD
ELDN SG&A Expenses
Latest reported$4.64Mperiod ending
Latest reported$4.64Mperiod ending
ELDN Quarterly SG&A Expenses ($661.00K → $4.64M)
Quarterly SG&A Expenses
High-resolution chart · PNG
ELDN sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 4,639,000 | |
| 3,984,000 | |
| 3,993,000 | |
| 4,101,000 | |
| 4,457,000 | |
| 4,433,000 | |
| 6,768,000 | |
| 3,990,000 | |
| 4,396,000 | |
| 3,459,000 | |
| 3,271,000 | |
| 3,267,000 | |
| 3,153,000 | |
| 2,997,000 | |
| 2,790,000 | |
| 3,146,000 | |
| 3,540,000 | |
| 3,224,000 | |
| 3,203,000 | |
| 2,848,000 | |
| 3,729,000 | |
| 3,352,000 | |
| 3,322,000 | |
| 3,731,000 | |
| 1,269,000 | |
| 1,730,000 | |
| 967,000 | |
| 1,411,000 | |
| 1,792,000 | |
| 1,886,000 | |
| 1,837,000 | |
| 1,848,000 | |
| 1,860,000 | |
| 1,698,000 | |
| 1,612,000 | |
| 2,448,000 | |
| 6,133,000 | |
| 906,000 | |
| 2,724,000 | |
| 564,000 | |
| 340,000 | |
| 3,549,000 | |
| 3,339,000 | |
| 3,416,000 | |
| 3,127,000 | |
| 2,741,000 | |
| 2,457,000 | |
| 3,599,000 | |
| 1,493,000 | |
| 1,336,000 | |
| 1,200,000 | |
| 661,000 |